{"entity":{"id":"karen-kelly","kind":"person","name":"Karen Kelly","aka":[],"tldr":"Thoracic medical oncologist who serves as CEO of the International Association for the Study of Lung Cancer.","summary":"Karen Kelly is Chief Executive Officer of the International Association for the Study of Lung Cancer (IASLC). A thoracic medical oncologist, she previously led cooperative-group lung cancer trials in the United States and held academic leadership roles before moving to lead the society. She oversees IASLC's scientific meetings, staging project and global education programmes.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://www.iaslc.org/learn-about-us/board-directors"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kelly+K%5BAuthor%5D+lung+cancer"}],"tags":["leadership","clinician-scientist","lung cancer"],"related":[],"cancers":["nsclc","sclc","mesothelioma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["iaslc"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Chief Executive Officer","institutionId":"iaslc","specialisms":["Thoracic oncology","Lung cancer clinical trials","Professional society leadership"],"profiles":[{"label":"Society page","url":"https://www.iaslc.org/learn-about-us/board-directors"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kelly+K%5BAuthor%5D+lung+cancer"}],"papers":[{"title":"Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer","journal":"Journal of Thoracic Oncology","year":2024,"doi":"10.1016/j.jtho.2024.06.010"},{"title":"The 2024 International Association for the Study of Lung Cancer Global Survey on Biomarker Testing","journal":"Journal of Thoracic Oncology","year":2025,"doi":"10.1016/j.jtho.2025.07.114"},{"title":"Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial","journal":"Nature Communications","year":2023,"doi":"10.1038/s41467-023-40813-w"}]},"route":"/people/karen-kelly/","neighbours":{"cancer":[{"id":"mesothelioma","kind":"cancer","name":"Mesothelioma","route":"/cancers/mesothelioma/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"institution":[{"id":"iaslc","kind":"institution","name":"International Association for the Study of Lung Cancer","route":"/institutions/iaslc/"}],"trial":[{"id":"lung-map","kind":"trial","name":"Lung-MAP (SWOG S1400 and S1900)","route":"/trials/lung-map/"}]}}